• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量阿立哌唑可减弱右旋苯丙胺的主观效应。

A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.

作者信息

Stoops William W, Lile Joshua A, Glaser Paul E A, Rush Craig R

机构信息

Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington, 40536-0086, USA.

出版信息

Drug Alcohol Depend. 2006 Sep 15;84(2):206-9. doi: 10.1016/j.drugalcdep.2006.02.004. Epub 2006 Mar 15.

DOI:10.1016/j.drugalcdep.2006.02.004
PMID:16540264
Abstract

Despite increased reports of amphetamine abuse and dependence, a putative pharmacotherapy has yet to be identified. In a previous study from our laboratory, 20 mg aripiprazole, an atypical antipsychotic that has partial agonist activity at D(2) receptors, attenuated many of the behavioral effects of d-amphetamine. Aripiprazole (20 mg) also impaired performance on a computerized version of the DSST when administered alone, indicating that the attenuation observed may have been functional as opposed to receptor mediated. The present experiment was conducted to determine whether a lower dose of aripiprazole (10 mg) could acutely attenuate the discriminative-stimulus, subject-rated, and physiological effects of d-amphetamine (2.5-15 mg) without impairing performance as measured with a computerized version of the DSST. The results of the present experiment indicate that 10 mg aripiprazole attenuated some abuse-related behavioral effects of d-amphetamine and was generally devoid of effects, including significant performance impairment, when administered alone. These findings suggest that 10 mg aripiprazole would be a reasonable starting dose for the treatment of stimulant abuse and dependence. Future research should examine the effects of chronic aripiprazole administration in combination with methamphetamine or cocaine.

摘要

尽管苯丙胺滥用和依赖的报告有所增加,但尚未确定一种假定的药物疗法。在我们实验室之前的一项研究中,20毫克阿立哌唑(一种在D(2)受体上具有部分激动剂活性的非典型抗精神病药物)减弱了右旋苯丙胺的许多行为效应。单独给药时,阿立哌唑(20毫克)也会损害计算机化版本的数字符号替换测验(DSST)的表现,这表明观察到的减弱可能是功能性的,而非受体介导的。进行本实验是为了确定较低剂量的阿立哌唑(10毫克)是否能在不损害计算机化版本的DSST所测量的表现的情况下,急性减弱右旋苯丙胺(2.5 - 15毫克)的辨别刺激、受试者评分和生理效应。本实验结果表明,10毫克阿立哌唑减弱了右旋苯丙胺一些与滥用相关的行为效应,并且单独给药时通常没有影响,包括显著的表现损害。这些发现表明,10毫克阿立哌唑将是治疗兴奋剂滥用和依赖的合理起始剂量。未来的研究应考察长期给予阿立哌唑与甲基苯丙胺或可卡因联合使用的效果。

相似文献

1
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.低剂量阿立哌唑可减弱右旋苯丙胺的主观效应。
Drug Alcohol Depend. 2006 Sep 15;84(2):206-9. doi: 10.1016/j.drugalcdep.2006.02.004. Epub 2006 Mar 15.
2
Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.阿立哌唑作为治疗兴奋剂依赖的潜在药物疗法:使用右旋苯丙胺的人体实验室研究。
Exp Clin Psychopharmacol. 2006 Nov;14(4):413-21. doi: 10.1037/1064-1297.14.4.413.
3
Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans.单独使用可卡因以及与阿立哌唑联合使用时对人类的辨别刺激、主观评价和心血管效应。
J Psychopharmacol. 2011 Nov;25(11):1469-79. doi: 10.1177/0269881110385597. Epub 2010 Oct 15.
4
Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.阿立哌唑可减弱D-苯丙胺对人类的辨别刺激和主观评定效应。
Neuropsychopharmacology. 2005 Nov;30(11):2103-14. doi: 10.1038/sj.npp.1300803.
5
Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).用于治疗兴奋剂滥用的药物:基于激动剂的策略及混合作用D2部分激动剂阿立哌唑(安律凡)的临床前评估
Exp Clin Psychopharmacol. 2008 Dec;16(6):475-83. doi: 10.1037/a0014398.
6
The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance.在阿立哌唑维持治疗期间急性鼻内给予可卡因的安全性、耐受性及受试者评定的效果。
Am J Drug Alcohol Abuse. 2007;33(6):769-76. doi: 10.1080/00952990701651556.
7
Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania.非典型抗精神病药阿立哌唑在基于 d-苯丙胺的狂躁症临床前模型中的疗效。
Int J Neuropsychopharmacol. 2010 May;13(4):541-8. doi: 10.1017/S1461145709991143. Epub 2010 Jan 5.
8
Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.阿立哌唑预处理对人类甲基苯丙胺强化效应的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:111-7. doi: 10.1016/j.pnpbp.2013.08.007. Epub 2013 Aug 28.
9
Attenuation of reinforcing and psychomotor stimulant effects of amphetamine by aripiprazole.阿立哌唑减弱安非他命的强化和精神运动刺激作用。
Addict Biol. 2011 Jan;16(1):55-63. doi: 10.1111/j.1369-1600.2010.00223.x.
10
Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.奥沙西泮不会调节右旋苯丙胺对人类的行为影响。
Pharmacol Biochem Behav. 2005 Oct;82(2):270-9. doi: 10.1016/j.pbb.2005.08.012. Epub 2005 Sep 22.

引用本文的文献

1
The influence of dopamine autoreceptors on temperament and addiction risk.多巴胺自身受体对气质和成瘾风险的影响。
Neurosci Biobehav Rev. 2023 Dec;155:105456. doi: 10.1016/j.neubiorev.2023.105456. Epub 2023 Nov 3.
2
A mechanistic overview of approaches for the treatment of psychostimulant dependence.治疗精神兴奋剂依赖方法的机制概述。
Front Pharmacol. 2022 Sep 8;13:854176. doi: 10.3389/fphar.2022.854176. eCollection 2022.
3
Clinical neuropharmacology of cocaine reinforcement: A narrative review of human laboratory self-administration studies.
可卡因强化的临床神经药理学:人类实验室自我给药研究的叙述性综述。
J Exp Anal Behav. 2022 May;117(3):420-441. doi: 10.1002/jeab.744. Epub 2022 Mar 1.
4
Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment.阿立哌唑用于可卡因戒断:一项采用生态瞬时评估的随机对照试验。
Behav Pharmacol. 2017 Feb;28(1):63-73. doi: 10.1097/FBP.0000000000000268.
5
Human drug discrimination: A primer and methodological review.人类药物辨别:入门指南与方法学综述。
Exp Clin Psychopharmacol. 2016 Aug;24(4):214-28. doi: 10.1037/pha0000077.
6
Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.阿立哌唑预处理对人类甲基苯丙胺强化效应的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:111-7. doi: 10.1016/j.pnpbp.2013.08.007. Epub 2013 Aug 28.
7
Relationship between drug discrimination and ratings of subjective effects: implications for assessing and understanding the abuse potential of D-amphetamine in humans.药物辨别与主观效应评分之间的关系:对评估和理解人类中右旋苯丙胺滥用潜力的启示。
Behav Pharmacol. 2013 Sep;24(5-6):523-32. doi: 10.1097/FBP.0b013e328364505f.
8
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.阿立哌唑治疗甲基苯丙胺依赖:一项随机、双盲、安慰剂对照试验。
Addiction. 2013 Apr;108(4):751-61. doi: 10.1111/add.12073. Epub 2013 Jan 3.
9
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings.奖赏回路功能障碍与精神神经发育障碍和遗传综合征:动物模型与临床研究发现。
J Neurodev Disord. 2012 Jul 6;4(1):19. doi: 10.1186/1866-1955-4-19.
10
Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance.长效阿普唑仑维持治疗期间急性经鼻吸食 methamphetamine 对生理和主观的影响。
Drug Alcohol Depend. 2011 Dec 15;119(3):187-93. doi: 10.1016/j.drugalcdep.2011.06.006. Epub 2011 Jul 6.